🟢 Sellas Life Sciences is trading 5.3% up on October 13, 2026 with no confirmed explanation

Sellas Life Sciences is trading at $12.56, up 5.32%, with no confirmed explanation for the October 13 rise.

• Investors are watching Phase 3 REGAL, reported at 78 of 80 events needed for final analysis, and expected Q4 SLS009 data.
• M&A or partnership speculation around a reserved ASH meeting booth remains unconfirmed social-media talk, not a company announcement.
• The biotech sector fell 2.01%; major indexes were modestly lower, offering no clear explanation for the gain.